KRAS and neoplasm: With regard to the carryover of genetic mutations from patient NSCLC tissues to mouse xenograft tissues, data from our study showed that genotypes are consistent between the original patient tumor and the corresponding xenograft tissue in all ten models for EGFR and KRAS status.